European Archives - Page 631 of 1332 - European Medical Journal

Gaurav Sanganee

Beating budget cuts and quick wins for pharma marketers

In this episode, Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, discusses creating modular content and leveraging AI within the pharma industry.

Interview: Andrew R.J. Mitchell

Andrew R.J. Mitchell | Consultant Cardiologist at Jersey General Hospital, Saint Helier, Jersey; Honorary Consultant Cardiologist at Oxford University Hospitals NHS Foundation Trust, UK

EAU23 Highlights: Best treatments for localised disease

Dr Alberto Bossi. During EAU23 in Milan, Dr Alberto Bossi discusses the most recent advances in treatments for localised disease.

EMJ

EAU23 Highlights: Advanced hormone sensitive prostate cancer

Prof. Bernd Schmitz-Dräger. On the third day of EAU23 in Milan, Professor Bernd Schmitz-Dräger presents highlights from the congress in advanced hormone sensitive prostate cancer treatment.

EAU23 Highlights: Screening, early detection and advanced prostate cancer

Professor Peter Hammerer. On the final day of EAU23 in Milan, Professor Peter Hammerer provides updates from the congress on screening, early detection and advanced prostate cancer.

IME Gastroenterology Webinar | Key Insights from ECCO 2023 - An Interdisciplinary Expert Roundtable Discussion

The interdisciplinary expert roundtable discussion covers ECCO 2023, new data on anti-TNFs and real-world evidence with biosimilars and more.

A Joint Conversation: Treating Rheumatic Disease

Giovanni Adami and Jonathan discuss rheumatoid arthritis, osteoporosis, and metabolic bone disease, including their symptoms and treatments.

Interview: Timothy Clinton

Timothy Clinton – Urologic Oncologist and Associate Surgeon, Dana–Farber Cancer Institute and Brigham and Women’s Hospitals, Boston, Massachusetts, USA; Faculty Member, Harvard University, Boston, USA.

Osteoarthritis: Redefining the Way We Consider This Chronic Condition

In this first podcast, Ali Mobasheri and Daniel White discuss why OA is a serious disease and how it’s burden of disease impacts individuals and society.

Matt Lewis

AI, ChatGPT and modernising medical affairs

This week, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in pharma.